Literature DB >> 18852041

Decreased expression of peroxiredoxin 6 in a mouse model of ethanol consumption.

James R Roede1, Benjamin J Stewart, Dennis R Petersen.   

Abstract

Alcoholic liver disease is multifactorial and oxidative stress is believed to play an intimate role in the initiation and progression of this pathology. The goals of this study were to investigate the effect of chronic ethanol treatment on inducing hepatic oxidative stress and peroxiredoxin 6 expression. After 9 weeks of treatment with an ethanol-containing diet, significant increases in serum ALT activity, liver to body weight ratio, liver triglycerides, CYP2E1 protein expression, and CYP2E1 activity were observed. Chronic ethanol feeding resulted in oxidative stress as evidenced by decreases in hepatic glutathione content and increased deposition of 4-hydroxynonenal and 4-oxononenal protein adducts. In addition, novel findings of decreased PRX6 protein and mRNA and increased levels of carbonylated PRX6 protein were observed in the ethanol-treated animals compared to the pair-fed controls. Lastly, NF-kappaB activity was found to be significantly increased in the ethanol-treated animals. Concurrent with the increase in NF-kappaB activity, decreases in both MEK1/2 and ERK1/2 phosphorylation were also observed in the ethanol-treated animals compared to the pair-fed controls. Together, these data demonstrate that chronic ethanol treatment results in oxidative stress, implicating NF-kappaB activation as an integral mechanism in the negative regulation of PRX6 gene expression in the mouse liver.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18852041     DOI: 10.1016/j.freeradbiomed.2008.08.032

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  24 in total

1.  Protein carbonylation in a murine model for early alcoholic liver disease.

Authors:  James J Galligan; Rebecca L Smathers; Kristofer S Fritz; L E Epperson; Lawrence E Hunter; Dennis R Petersen
Journal:  Chem Res Toxicol       Date:  2012-05-01       Impact factor: 3.739

2.  Mitochondrial acetylome analysis in a mouse model of alcohol-induced liver injury utilizing SIRT3 knockout mice.

Authors:  Kristofer S Fritz; James J Galligan; Matthew D Hirschey; Eric Verdin; Dennis R Petersen
Journal:  J Proteome Res       Date:  2012-02-21       Impact factor: 4.466

Review 3.  Peroxiredoxin 6: a bifunctional enzyme with glutathione peroxidase and phospholipase A₂ activities.

Authors:  Aron B Fisher
Journal:  Antioxid Redox Signal       Date:  2011-03-31       Impact factor: 8.401

4.  4-Hydroxynonenal inhibits SIRT3 via thiol-specific modification.

Authors:  Kristofer S Fritz; James J Galligan; Rebecca L Smathers; James R Roede; Colin T Shearn; Philip Reigan; Dennis R Petersen
Journal:  Chem Res Toxicol       Date:  2011-04-14       Impact factor: 3.739

Review 5.  Redox signaling and the innate immune system in alcoholic liver disease.

Authors:  Jessica I Cohen; Xiaocong Chen; Laura E Nagy
Journal:  Antioxid Redox Signal       Date:  2011-05-25       Impact factor: 8.401

6.  Oxidative stress-mediated aldehyde adduction of GRP78 in a mouse model of alcoholic liver disease: functional independence of ATPase activity and chaperone function.

Authors:  James J Galligan; Kristofer S Fritz; Donald S Backos; Colin T Shearn; Rebecca L Smathers; Hua Jiang; Kenneth N MacLean; Philip R Reigan; Dennis R Petersen
Journal:  Free Radic Biol Med       Date:  2014-06-09       Impact factor: 7.376

Review 7.  Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease.

Authors:  Rebecca L Smathers; James J Galligan; Benjamin J Stewart; Dennis R Petersen
Journal:  Chem Biol Interact       Date:  2011-02-24       Impact factor: 5.192

8.  Phosphatase and tensin homolog deleted on chromosome 10 (PTEN) inhibition by 4-hydroxynonenal leads to increased Akt activation in hepatocytes.

Authors:  Colin T Shearn; Rebecca L Smathers; Benjamin J Stewart; Kristofer S Fritz; James J Galligan; Numsen Hail; Dennis R Petersen
Journal:  Mol Pharmacol       Date:  2011-03-17       Impact factor: 4.436

9.  Peroxiredoxin 6 fails to limit phospholipid peroxidation in lung from Cftr-knockout mice subjected to oxidative challenge.

Authors:  Stéphanie Trudel; Mairead Kelly; Janine Fritsch; Thao Nguyen-Khoa; Patrice Thérond; Martine Couturier; Michal Dadlez; Janusz Debski; Lhousseine Touqui; Benoit Vallée; Mario Ollero; Aleksander Edelman; Franck Brouillard
Journal:  PLoS One       Date:  2009-06-29       Impact factor: 3.240

10.  Overexpression of peroxiredoxin 6 does not prevent ethanol-mediated oxidative stress and may play a role in hepatic lipid accumulation.

Authors:  James R Roede; David J Orlicky; Aron B Fisher; Dennis R Petersen
Journal:  J Pharmacol Exp Ther       Date:  2009-04-22       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.